**CORRIGENDUM FOR 10.1210/jc.2016-2660**

In the article "Is a Normal TSH Synonymous With "Euthyroidism" in Levothyroxine Monotherapy?" by Peterson*et al.* (*J Clin Endocrinol Metab.* 101(12):4964--4973, 2016; doi:10.1210/jc.2016-2660; First Published October 4, 2016) the authors report the following typographical error in the published paper: In reference to our recent publication ([@bib1]), we were prompted by our colleagues to the fact that the difference in cognitive/wellbeing parameters on Table 2 were borderline significant when comparing levothyroxine users matched 1:1 for age, sex, race/ethnicity, and TSH level to healthy controls. After conferring with a statistician in our institution we were advised to reanalyze the two populations using healthy control individuals matched 2:1 for age, sex, race/ethnicity, and TSH level (levothyroxine users n= 469 vs matched controls n=938). While applying the same statistical tests ([@bib1]), the new 2:1 analysis confirmed ALL of our original findings described on Tables 1 and 2 for the objective measures, METs, and nutrient intake parameters. In addition, the differences in two of the cognitive/wellbeing parameters were now found to be statistically significant on the 2:1 analysis,*i.e.* increased likelihood to experience confusion/memory problems (13% vs 10%,*P* = 0.03) and decreased likelihood to state "excellent" or "good" health condition (32% vs 42%,*P* = 0.001) compared with matched controls. In fact, these are two frequent complaints reported by our levothyroxine-treated patients. Thus, we thought the readers of this journal would benefit from learning about this new data, revealing cognitive impairment in levothyroxine treated individuals in a large population study.

*The compositor regrets this error*.
